(Hong Kong, 24 August 2017) – China Resources Pharmaceutical Group Limited (CR Pharma) (stock code: 3320), announced its interim results for the six months ended 30 June 2017 (“Re...

(Hong Kong, 24 August 2017) – China Resources Pharmaceutical Group Limited (CR Pharma) (stock code: 3320), announced its interim results...

Detailed>>

Detailed +

2017.08

2017.08.25

China Resources Pharmaceutical Delivers Solid Interim Results

(Hong Kong, 24 August 2017) – China Resources Pharmaceutical Group Limited (CR Pharma) (stock code: 3320), announced its interim results...

2017.08

2017.08.07

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceutical Industry in 2016”

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceut...

Recently, the Southern Medicine Economic Institute of China Food and Drug Administration (CFDA) releases “Top 100 of Chinese Pharmaceuti...

2017.06

2017.06.26

CR Pharma is officially included in the FTSE global equity index

China Resources Pharmaceutical Group Limited Group (CR Pharma) (stock code: 3320.HK) is included in the FTSE Global Equity Index Series (...

2017.06

2017.06.19

CR Pharma Releases Sustainable Development Report 2016

On June 16th, China Resources Pharmaceutical Group Co., Ltd. (CR Pharma) published its Sustainable Development Report 2016 on the website...

2017.04

2017.04.05

CRPG Signed Strategic Business Alliance with Fujifilm

On March 31st, 2017, China Resources Pharmaceutical Group (CR Pharma) signed agreement for Strategic Business Alliance with Fujifilm Corp...

2017.02

2017.02.23

The CEO of Reckitt Benckiser Visited CR Pharma

On February 21st, Mr.Wang Chuncheng, the executive Director, the CEO and the President of China Resources Pharmaceutical Company Limited ...

2016.12

2016.12.14

CR Pharma Collaborates with WuXi AppTec on Two Innovative Drugs Again

On the morning of December 12, 2016, China Resources Pharmaceutical Group Co., Ltd. (hereinafter: CR Pharma) and WuXi AppTec(Shanghai) Co...